Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
- Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
- Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
- Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
- Linezolid or Vancomycin Surgical Site Infection Prophylaxis
- Linezolid Pilot Study
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
- Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease
- FOUR-SIX TRIAL for the Treatment of Enterococcal Endocarditis
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- BPaL Regimen in FQ Resistant MDR-TB
- Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
- NextGen - Clinical Implication of Next Generation Sequencing
- Alternative Antibiotics for Syphilis
- Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
- Linezolid Dosing Strategies in Drug-Resistant TB
- Imipenem, Cilastatin Sodium, and Relebactam Monohydrate for the Treatment of Cancer Patients With Febrile Neutropenia
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
- Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
- Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
- Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
- Economic Evaluation of New MDR TB Regimens
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
- PRACTECAL-PKPD Sub Study
- Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
- Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
- Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
- Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
- Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
- Linezolid in Healthy Volunteers
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
- Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
- Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
- Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
- Pharmacokinetic Study of Linezolid for TB Meningitis
- Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
- Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
- Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
- Tedizolid Prolonged Treatment for Prosthetic Joint Infections
- Linezolid for Treatment of Nontuberculous Mycobacterial Diseases
- Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNix)
- Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
- Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis
- Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
- Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis
- Evaluating Newly Approved Drugs for Multidrug-resistant TB
- Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
- Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
- Treatment Shortening of MDR-TB Using Existing and New Drugs
- AbioKin - Antibiotic Kinetics
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
- Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
- Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
- Using Sodium Lactate Ringer's Injection Resuscitate Septic Shock Patients
- Study of Debio 1450 for Bacterial Skin Infections
- Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
- A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis
- A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)
- A P3 Comparator Trial in Community Acquired Bacterial Pneumonia
- MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
- Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
- Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
- Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
- Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis
- Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
- Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia
- Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
- Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
- Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
- Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
- Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
- Concentration of Antimicrobials in Catheter-lock Solutions
- Post Marketing Surveillance Study on Linezolid
- Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
- A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
- Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males
- Daptomycin in Pediatric Patients With Bacterial Meningitis
- Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
- Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
- A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
- Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)
- GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
- Population Pharmacokinetics of Linezolid
- TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
- Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)
- Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects
- Cost Effectiveness Of Linezolid In Central America
- A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and th
- Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers
- Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
- Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
- Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
- Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
- Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
- The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
- A Study To Assess The Effect Of Linezolid On QTc Interval
- Linezolid to Treat Extensively-Drug Resistant Tuberculosis
- Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
- Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)
- Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults
- Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)
- TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB
- Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
- Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
- Pharmacokinetics of Linezolid in Children With Cystic Fibrosis
- Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
- Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
- Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
- Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
- Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
- Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)
- Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)
- Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
- Evaluation Of Linezolid Pk Profile In Burns Patients
- Ceftobiprole in Hospital Acquired Pneumonia
- Ceftobiprole in Hospital Acquired Pneumonia
- Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
- Time To Efficacy and Onset Of Action Of Linezolid
- Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
- Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
- New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
- Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
- New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Clinical trials list
click for details